Main Article Content


In this study used to assess whether the effect of clinical pharmacist intervention on patient education shows a significant difference about the medication’s usage is beneficial to patient or not. Adequate knowledge on medication usage helps paediatric patients to prevent disease progression, relieve symptoms, improve health status, prevent and treat complications, reduce mortality. Also assess whether the pharmacist-patient communication makes a significant difference to patient health outcomes. Its useful to find the progress of symptom resolution to normal condition and provide drug information services. Also find out major drug interactions and adverse drug reactions in prescription.


Clinical pharmacy, Drug related Problems (DRP’s), Paediatrics, Pharmacotherapy, Intervention, Drug therapy.

Article Details

How to Cite
M. Bramhini, P. Ramya, P. Praneeth Nikhilson, & P. Soumya. (2022). Clinical Pharmacist Intervention on Paediatric Patients in Tertiary Care Hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics, 11(1), 36-46. Retrieved from


  1. 1. Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104(3 Pt 2):585-90. doi: 10.1542/peds.104.S3.585, PMID 10469794.
  2. 2. Roberts Rosemary, Rodriguez William, Murphy Dianne, Crescenzi Terrie. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003;290(7):905-11. doi: 10.1001/jama.290.7.905, PMID 12928467.
  3. 3. FDA. gov. Food and Drug Administration Modernization Act of 1997; March 8, 2015. Available from:
  4. 4. FDA. gov. Best Pharmaceuticals for children Act; January 4, 2002 [cited Mar 8, 2015]. Available from:
  5. 5. Makowsky Mark J, Schindel Theresa J, Rosenthal Meagen, Campbell Katy, Tsuyuki Ross T, Madill Helen M. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care. 2009;23(2):169-84. doi: 10.1080/13561820802602552, PMID 19234987.
  6. 6. Promoting safety of medicines for children. World Health Organization. ISBN 978-92-4-156343-7.
  7. 7. Borad Mihirkumar P, Suares Ashley G, Nanjwade Basavaraj K. Evaluation and effect of patient counselling in a tertiary care teaching hospital at bengaluru by pharmd students. World J Pharm Pharm Sci. 2015;5(1):931-94.
  8. 8. Kelishadi Roya, Mousavinasab Firoozeh. Rational use of medicine in the pediatric age group: A summary on the role of clinical pharmacists. J Res Pharm Pract. July–September 2012;1(1):10-3. doi: 10.4103/2279-042X.99671, PMID 24991581.
  9. 9. Jose Binila, Shareef Javedh, Rathika Shenoy. Assessment of drug related problems and pharmacist interventions in pediatric drug therapy in a tertiary care teaching hospital. Am J PharmTech Research. 2016;6(2):209-18. doi: 10.18203/2319-2003.ijbcp20183926
  10. 10. Kumar Satish, bp, dahal Prasanna, venkataraman Rajesh, fuloria Prashant chandra. Assessment of clinical pharmacist intervention in tertiary care teaching hospital of southern India. Asian J Pharm Clin Res. 2013 March 31;6(2):258-61.
  11. 11. Khayam Umar et al. Medication errors assessment and prevention by a clinical pharmacist in pediatric wards of RMI hospital Peshawar, KPK-Pakistan. Ann. Pak. Inst. Med Sci. 2015;11(3):124-9. Available from: Prevention%20by%20a%20Clinical%20Pharmacist.pdf
  12. 12. Mahendra Kumar BJ, Sandeep A, Krishnagoudar Bhimaray S, Venkappa Katti Ravi, Ramanath KV. Assessment and Evaluation of Drug Information Services provided by the Clinical Pharmcists in a rural tertiary care Teaching Hospital of South India. RGUHS J Pharm Sci. 2011;1(1):26. Available from:
  13. 13. Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Van Paesschen W. Interaction between valproate and meropenem: a retrospective study, National Institutes of Health. 2007 July;41(7):1130-6. Available from: